Optimizing Tattoo Removal: a Side-by-side Comparison in the Search for One Treatment Tattoo Removal

Tattoo Removal Clinical Trial

Official title:

Optimizing Tattoo Removal: a Side-by-side Comparison in the Search for One Treatment Tattoo Removal

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01624688
• Other study ID #: 2011P001091
• Status: Completed
• Phase: N/A
• Start date: July 2011
• Est. completion date: December 2011

Study information

• Verified date: October 2019
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to combine treatment options for tattoo removal in an attempt to completely remove a tattoo in one visit.

Description:

Efficient tattoo removal is of special concern to dermatology, where tattoo removal is a common request. Current tattoo removal techniques using once monthly treatment with quality-switched (QS) lasers are relatively effective, but not efficient. Numerous treatments are required and complete removal of ink is usually rare, making the process time-consuming, expensive and, sometimes, disappointing. The broad objective of this study is to combine effective methods for tattoo removal based on current knowledge to establish a protocol which significantly improves laser tattoo removal, aiming to selectively remove most tattoos in one office visit.

The proposed study is a prospective, side-by-side comparison of four tattoo treatment protocols using a combination of ablative fractional and q-switched (QS) laser techniques. 32 subjects with tattoos recruited from the community will receive all four treatments, one on each randomly-assigned, equal quadrant of the same tattoo. The different treatment protocols are as follows: 1. one round of QS laser treatment, which is the current treatment standard

2. four repeat treatments with the QS laser with a 20 minute delay in between 3. four repeat treatments at 20 minute intervals with the QS laser combined with an ablative fractional laser treatment 4. four repeat treatments at 20 minute intervals with the QS laser plus treatment with the ablative fractional laser, in combination with topical urea application. Following this initial round of treatments, the subject will have the option to choose his or her preferred treatment protocol which will then be used to treat the entire tattoo again one month later. Previous studies indicate that the majority of tattoos will be completely or nearly completely removed in this study, providing a potential benefit to those who enroll in the study. The primary measures of efficacy are (a) blinded evaluation of improvement from standard digital photographs taken before and after the treatments, including number of tattoos that are completely gone, and (b) digital analysis of tattoo removal from those photos. Other study endpoints include patient's preferred removal technique, evaluation of tattoo ink on dressings, inflammatory and pigmentary alterations and changes in skin texture.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Subjects between the ages of 18 and 50 years old, male or female.

• Subjects with tattoos that are between 16 and 400 cm2, both amateur and professional

• Willingness to participate in the study

• Willingness to shield tattoo completely from sun exposure

• Willingness to receive EXPERIMENTAL treatment

• Informed consent agreement signed by the subject

• Willingness to follow the treatment schedule and post treatment care requirements

Exclusion Criteria:

• Subjects with recent sun exposure and suntan in the area to be treated

• Allergic tattoos (hypersensitivity to tattoo ink)

• History of vitiligo

• Tattoos located on the neck or face

• Subjects unwilling to tolerate partial removal of the tattoo in this study

• Infection or skin disease in the area to be treated

• Subjects who are immunosuppressed

• Subject is unable to comply with treatment, home care or follow-up visits

• Subject is pregnant or nursing

• Allergy to lidocaine

• Liver failure

Related Conditions & MeSH terms

• Tattoo
• Tattoo Removal

Intervention

Procedure:
• Tattoo Removal
Tattoo removal with q-switched laser treatment, repeated q-switched laser treatment, repeated q-switched laser treatment with fractional ablative laser treatment, and repeated q-switched laser treatment with fractional ablative laser treatment and then topical urea

Locations

Country	Name	City	State
United States	Wellman Center for Photomedicine	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tattoo Clearance		2 months after treatment
Secondary	Patient's preferred removal technique		2 months after treatment
Secondary	Post treatment skin changes	inflammatory and pigmentary alterations and changes in skin texture after treatment	2 months after treatment